As the clinical use of GLP-1 receptor agonists (RA) expands beyond diabetes and obesity, clinicians must balance emerging cardiometabolic and organ-specific benefits with the challenges of persistent...
As the clinical use of GLP-1 receptor agonists (RA) expands beyond diabetes and obesity, clinicians must balance emerging cardiometabolic and organ-specific benefits with the challenges of persistent...
As the clinical use of GLP-1 receptor agonists (RA) expands beyond diabetes and obesity, clinicians must balance emerging cardiometabolic and organ-specific benefits with the challenges of persistent...
As the clinical use of GLP-1 receptor agonists (RA) expands beyond diabetes and obesity, clinicians must balance emerging cardiometabolic and organ-specific benefits with the challenges of persistent...
In this multidisciplinary discussion, family medicine experts demonstrate how integrated team-based models, spanning primary care, behavioral health, pharmacy, and community services, can improve outcomes,...
In this multidisciplinary discussion, family medicine experts demonstrate how integrated team-based models, spanning primary care, behavioral health, pharmacy, and community services, can improve outcomes,...
A new study comparing robotic and laparoscopic cholecystectomies found no significant difference in perioperative opioid use or operative time between the two approaches. These findings were presented at...
A new study comparing robotic and laparoscopic cholecystectomies found no significant difference in perioperative opioid use or operative time between the two approaches. These findings were presented at...
A new study comparing robotic and laparoscopic cholecystectomies found no significant difference in perioperative opioid use or operative time between the two approaches. These findings were presented at...
A new study comparing robotic and laparoscopic cholecystectomies found no significant difference in perioperative opioid use or operative time between the two approaches. These findings were presented at...
